Literature DB >> 16750892

Role of adenosine A1 receptors in the modulation of dopamine D1 and adenosine A2A receptor signaling in the neostriatum.

K Yabuuchi1, M Kuroiwa, T Shuto, N Sotogaku, G L Snyder, H Higashi, M Tanaka, P Greengard, A Nishi.   

Abstract

Adenosine is known to modulate the function of neostriatal neurons. Adenosine acting on A(2A) receptors increases the phosphorylation of dopamine- and cAMP-regulated phosphoprotein of M(r) 32 kDa (DARPP-32) at Thr34 (the cAMP-dependent protein kinase [PKA] site) in striatopallidal neurons, and opposes dopamine D2 receptor signaling. In contrast, the role of adenosine A(1) receptors in the regulation of dopamine/DARPP-32 signaling is not clearly understood. Here, we investigated the effect of adenosine A(1) receptors on D(1), D(2) and A(2A) receptor signaling using mouse neostriatal slices. An A(1) receptor agonist, 2-chloro-N(6)-cyclopentyladenosine (100 nM), caused a transient increase, followed by a transient decrease, in DARPP-32 Thr34 phosphorylation. Our data support the following model for the actions of the A(1) receptor agonist. The A(1) receptor-induced early increase in Thr34 phosphorylation was mediated by presynaptic inhibition of dopamine release, and the subsequent removal of tonic inhibition by D(2) receptors of A(2A) receptor/G(olf)/cAMP/PKA signaling. The A(1) receptor-induced late decrease in Thr34 phosphorylation was mediated by a postsynaptic G(i) mechanism, resulting in inhibition of D(1) and A(2A) receptor-coupled G(olf)/cAMP/PKA signaling in direct and indirect pathway neurons, respectively. In conclusion, A(1) receptors play a major modulatory role in dopamine and adenosine receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16750892     DOI: 10.1016/j.neuroscience.2006.04.047

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  24 in total

Review 1.  Genetics of caffeine consumption and responses to caffeine.

Authors:  Amy Yang; Abraham A Palmer; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2010-06-09       Impact factor: 4.530

2.  Indirect basal ganglia pathway mediation of repetitive behavior: attenuation by adenosine receptor agonists.

Authors:  Yoko Tanimura; Sasha Vaziri; Mark H Lewis
Journal:  Behav Brain Res       Date:  2010-02-21       Impact factor: 3.332

3.  Evaluation of neuronal phosphoproteins as effectors of caffeine and mediators of striatal adenosine A2A receptor signaling.

Authors:  Bogachan Sahin; Stacey Galdi; Joseph Hendrick; Robert W Greene; Gretchen L Snyder; James A Bibb
Journal:  Brain Res       Date:  2006-12-06       Impact factor: 3.252

4.  The hydrolysis of striatal adenine- and guanine-based purines in a 6-hydroxydopamine rat model of Parkinson's disease.

Authors:  Jean Pierre Oses; Cristiane Batassini; Daniela Pochmann; Ana Elisa Böhmer; Fernanda Cenci Vuaden; Roberta Bristot Silvestrin; Alcyr Oliveira; Carla Denise Bonan; Maurício Reis Bogo; Diogo Onofre Souza; Luis Valmor Cruz Portela; João José de Freitas Sarkis; Tadeu Mello e Souza
Journal:  Neurochem Res       Date:  2010-11-04       Impact factor: 3.996

5.  Internalization and desensitization of adenosine receptors.

Authors:  Elisabeth C Klaasse; Adriaan P Ijzerman; Willem J de Grip; Margot W Beukers
Journal:  Purinergic Signal       Date:  2007-11-13       Impact factor: 3.765

6.  Modulation of Ca2+-currents by sequential and simultaneous activation of adenosine A1 and A 2A receptors in striatal projection neurons.

Authors:  O Hernández-González; T Hernández-Flores; G A Prieto; A Pérez-Burgos; M A Arias-García; E Galarraga; J Bargas
Journal:  Purinergic Signal       Date:  2013-09-07       Impact factor: 3.765

7.  Adenosine A1-Dopamine D1 Receptor Heteromers Control the Excitability of the Spinal Motoneuron.

Authors:  Marla Rivera-Oliver; Estefanía Moreno; Yocasta Álvarez-Bagnarol; Christian Ayala-Santiago; Nicole Cruz-Reyes; Gian Carlo Molina-Castro; Stefan Clemens; Enric I Canela; Sergi Ferré; Vicent Casadó; Manuel Díaz-Ríos
Journal:  Mol Neurobiol       Date:  2018-05-24       Impact factor: 5.590

8.  Chronic coffee consumption and striatal DAT-SPECT findings in Parkinson's disease.

Authors:  Angelo Fabio Gigante; Artor Niccoli Asabella; Giovanni Iliceto; Tommaso Martino; Cristina Ferrari; Giovanni Defazio; Giuseppe Rubini
Journal:  Neurol Sci       Date:  2018-01-23       Impact factor: 3.307

9.  Functional characterization of G-protein-coupled receptors: a bioinformatics approach.

Authors:  L Tovo-Rodrigues; A Roux; M H Hutz; L A Rohde; A S Woods
Journal:  Neuroscience       Date:  2014-07-02       Impact factor: 3.590

10.  Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum.

Authors:  Akinori Nishi; Mahomi Kuroiwa; Diane B Miller; James P O'Callaghan; Helen S Bateup; Takahide Shuto; Naoki Sotogaku; Takaichi Fukuda; Nathaniel Heintz; Paul Greengard; Gretchen L Snyder
Journal:  J Neurosci       Date:  2008-10-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.